Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2015101150
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Albuminuria and Endothelial Dysfunction in Patients With Non-Diabetic Chronic Kidney Disease

Medical Science Monitor
Medicine
2017English

Measuring Motor Complications in Clinical Trials for Early Parkinson's Disease

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2003English

Pronounced Kidney Hypoxia Precedes Albuminuria in Type 1 Diabetic Mice

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2016English

Determining Power in Clinical Trials

BMJ
1988English

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities

Kidney International Reports
Nephrology
2017English

Interleukin-17a Blockade Reduces Albuminuria and Kidney Injury in an Accelerated Model of Diabetic Nephropathy

Kidney International
Nephrology
2019English

Surrogate End Points for Clinical Trials of Kidney Disease Progression

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2006English

MicroRNAs in Diabetic Kidney Disease

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2014English

microRNAs in Diabetic Kidney Disease

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy